Cisplatin-induced emesis: Systematic review and meta-analysis of the ferret model and the effects of 5-HT3 receptor antagonists

Cancer Chemotherapy and Pharmacology

Volumn 67, Issue 3, 2011, Pages 667-686

  Percie Du Sert, N ^a   Rudd, J A ^b   Apfel, C C ^c   Andrews, P L R ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

5 HT3 receptor antagonist; Cisplatin; Emesis; Ferret; Granisetron; Meta analysis; Ondansetron; Systematic review; Tropisetron

Indexed keywords

AZASETRON; BEMESETRON; CISPLATIN; DOLASETRON MESILATE; GRANISETRON; INDISETRON; ONDANSETRON; RAMOSETRON; RENZAPRIDE; SEROTONIN ANTAGONIST; TROPISETRON; ZACOPRIDE; ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; SEROTONIN 3 ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMOTHERAPY INDUCED EMESIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FERRET; MALE; META ANALYSIS (TOPIC); NONHUMAN; PRIORITY JOURNAL; SYSTEMATIC REVIEW (TOPIC); TOXICITY TESTING; TREATMENT RESPONSE; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; HUMAN; META ANALYSIS; NAUSEA; REVIEW; TIME; VOMITING;

ANIMALS; ANTIEMETICS; ANTINEOPLASTIC AGENTS; CISPLATIN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FERRETS; HUMANS; NAUSEA; SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS; TIME FACTORS; VOMITING;

EID: 79953819995     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-010-1339-4     Document Type: Article

References (159)

1. Altman DG (1991) Practical statistics for medical research. Chapman & Hall, London
2. PLR Andrews CC Horn 2006 Signals for nausea and emesis: implications for models of upper gastrointestinal diseases Auton Neurosci 125 100 115 16556512
3. Andrews PLR, Rudd JA (2004) The role of tachykinins and the tachykinin NK1 receptor in nausea and emesis. In: Holzer P (ed) Handbook of experimental pharmacology. Springer, Berlin
4. I Angel H Schoemaker M Prouteau M Garreau SZ Langer 1993 Litoxetine: a selective 5-HT uptake inhibitor with concomitant 5-HT3 receptor antagonist and antiemetic properties Eur J Pharmacol 232 139 145 1:CAS:528:DyaK3sXitVGisrg%3D 8385615 (Pubitemid 23080188)
5. JM Barnes NM Barnes B Costall RJ Naylor FD Tattersall 1988 Reserpine, para-chlorophenylalanine and fenfluramine antagonise cisplatin-induced emesis in the ferret Neuropharmacology 27 783 790 1:CAS:528:DyaL1cXlsVansbY%3D 2905784
6. NM Barnes JM Barry B Costall RJ Naylor FD Tattersall 1987 Antagonism by para-chlorophenylalanine of cisplatin-induced emesis Br J Pharmacol 92 649P
7. NM Barnes KT Bunce RJ Naylor JA Rudd 1991 The actions of fentanyl to inhibit drug-induced emesis Neuropharmacology 30 1073 1083 1:CAS:528: DyaK3MXmsVOqsbc%3D 1661861
8. V Bebarta D Luyten K Heard 2003 Emergency medicine animal research: does use of randomization and blinding affect the results? Acad Emerg Med 10 684 687 12782533 (Pubitemid 36667073)
9. J Bermudez EA Boyle WD Miner GJ Sanger 1988 The anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694 Br J Cancer 58 644 650 1:CAS:528:DyaL1MXltFaltg%3D%3D 2851311 (Pubitemid 19010719)
10. P Bhandari YK Gupta SD Seth A Chugh 1988 Emetic profile of cisplatin in dogs Asia Pac J Pharmacol 3 131 133 1:CAS:528:DyaL1MXjtlCmug%3D%3D
11. S Bingham PR Blower PT Davey PD King GJ Sanger KA Wardle Y Nishioka 1994 Differences between the anti-emetic efficacies of the 5-HT3 receptor antagonists Granisetron and Azasetron in the conscious ferret Pharmacometrics 47 21 28 1:CAS:528:DyaK2cXhvVakt7k%3D (Pubitemid 24078957)
12. PR Blower 1990 The role of specific 5-HT3 receptor antagonism in the control of cytostatic drug-induced emesis Eur J Cancer 26 Suppl 1 S8 S11 1:CAS:528:DyaK3MXhslWrug%3D%3D 2169786
13. E Blum KH Buchheit HH Buecher R Gamse E Kloeppner H Meigel C Papageorgiou R Waelchli L Revesz 1992 Design and synthesis of novel ligands for the 5-HT4 and the 5-HT4 receptor Bioorg Med Chem Lett 2 461 466 1:CAS:528: DyaK3sXmt1Gktbc%3D
14. HL Borison SC Wang 1953 Physiology and pharmacology of vomiting Pharmacol Rev 5 193 230 1:CAS:528:DyaG3sXkvVOqsw%3D%3D 13064033
15. C Bountra K Bunce T Dale C Gardner C Jordan D Twissell P Ward 1993 Anti-emetic profile of a non-peptide neurokinin NK1 receptor antagonist, CP-99, 994, in ferrets Eur J Pharmacol 249 R3 R4 1:CAS:528:DyaK2cXksFKisg%3D%3D 7506663
16. E Chevalier L Singh L Diop 1998 Anti-emetic effects of PD154075 Gastroenterology 114 A578
17. RD Clark AB Miller J Berger DB Repke KK Weinhardt BA Kowalczyk RM Eglen DW Bonhaus CH Lee AD Michel, et al. 1993 2-(Quinuclidin-3-yl)pyrido[4, 3-b]indol-1-ones and isoquinolin-1-ones. Potent conformationally restricted 5-HT3 receptor antagonists J Med Chem 36 2645 2657 1:CAS:528:DyaK3sXltl2it70%3D 8410977 (Pubitemid 23294131)
18. B Costall AM Domeney SJ Gunning ME Kelly RJ Naylor V Nohria JB Owera-Atepo KM Simpson CC Tan D Tattersall 1987 The action of dazopride to enhance gastric emptying and block emesis Neuropharmacology 26 669 677 1:CAS:528:DyaL2sXkvV2ltrc%3D 3114664 (Pubitemid 17100432)
19. B Costall AM Domeney SJ Gunning RJ Naylor D Tattersall MB Tyers 1987 GR38032F: a potent and novel inhibitor of cisplatin-induced emesis in the ferret Br J Pharmacol 90 90P
20. B Costall AM Domeney RJ Naylor JB Owera-Atepo JA Rudd FD Tattersall 1990 Fluphenazine, ICS 205-930 and dl-fenfluramine differentially antagonise drug-induced emesis in the ferret Neuropharmacology 29 453 462 1:CAS:528:DyaK3cXktlCltrg%3D 1972549 (Pubitemid 20152561)
21. B Costall AM Domeney RJ Naylor FD Tattersall 1986 5-Hydroxytryptamine M-receptor antagonism to prevent cisplatin-induced emesis Neuropharmacology 25 959 961 1:CAS:528:DyaL28XlvVeksrk%3D 3774121 (Pubitemid 16045969)
22. B Costall AM Domeney RJ Naylor FD Tattersall 1987 Emesis induced by cisplatin in the ferret as a model for the detection of anti-emetic drugs Neuropharmacology 26 1321 1326 1:CAS:528:DyaL2sXlvFShsLk%3D 2890117 (Pubitemid 17154886)
23. B Costall RJ Naylor FD Tattersall 1990 The actions of fenfluramine and interaction with 5-HT3 receptor-antagonists to inhibit emesis in the ferret J Pharm Pharmacol 42 94 101 1:CAS:528:DyaK3cXktVSgurs%3D 1972409 (Pubitemid 20238637)
24. LX Cubeddu IS Hoffmann NT Fuenmayor AL Finn 1990 Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting N Engl J Med 322 810 816 1:STN:280:DyaK3c7nsVaguw%3D%3D 1689807 (Pubitemid 20094144)
25. TM Dando CM Perry 2004 Aprepitant: a review of its use in the prevention of chemotherapy-induced nausea and vomiting Drugs 64 777 794 1:CAS:528:DC%2BD2cXjvVOmtrk%3D 15025555 (Pubitemid 38471378)
26. Davis CJ (1988) Neuropharmacological investigations into the mechanisms of emesis caused by cytotoxic drugs and radiation. Clinical pharmacology. Oxford University, PhD thesis
27. P Delagrange MB Emerit N Merahi C Abraham P Morain S Rault P Renard B Pfeiffer B Guardiola-Lemaitre M Hamon 1996 Interaction of S 21007 with 5-HT3 receptors. In vitro and in vivo characterization Eur J Pharmacol 316 195 203 1:CAS:528:DyaK28Xnt1Krs7Y%3D 8982686 (Pubitemid 27008150)
28. R DerSimonian R Kacker 2007 Random-effects model for meta-analysis of clinical trials: an update Contemp Clin Trials 28 105 114 16807131 (Pubitemid 44937874)
29. RM Eglen DW Bonhaus RD Clark LG Johnson CH Lee E Leung WL Smith EH Wong RL Whiting 1994 (R) and (S) RS 56532: mixed 5-HT3 and 5-HT4 receptor ligands with opposing enantiomeric selectivity Neuropharmacology 33 515 526 1:CAS:528:DyaK2cXkt1Kht7k%3D 7984291 (Pubitemid 24168724)
30. RM Eglen CH Lee WL Smith LG Johnson R Clark RL Whiting SS Hegde 1995 Pharmacological characterization of RS 25259-197, a novel and selective 5-HT3 receptor antagonist, in vivo Br J Pharmacol 114 860 866 1:CAS:528: DyaK2MXjvFKnsbw%3D 7773547
31. RM Eglen CH Lee WL Smith LG Johnson RL Whiting SS Hegde 1993 RS 42358-197, a novel and potent 5-HT3 receptor antagonist, in vitro and in vivo J Pharmacol Exp Ther 266 535 543 1:CAS:528:DyaK2cXksFGqtQ%3D%3D 8355189 (Pubitemid 23318658)
32. T Endo M Minami Y Monma H Saito M Takeuchi 1990 Emesis-related biochemical and histopathological changes induced by cisplatin in the ferret J Toxicol Sci 15 235 244 1:CAS:528:DyaK3MXit1Sqsrw%3D 1707101
33. T Endo M Minami Y Monma M Yoshioka H Saito J Kinami Y Toshimitsu SH Parvez 1990 Effect of GR38032F on cisplatin- and cyclophosphamide-induced emesis in the ferret Biog Amines 7 525 533 1:CAS:528:DyaK3MXpsFShsw%3D%3D
34. T Endo M Minami Y Monma M Yoshioka H Saito SH Parvez 1992 Vagotomy and ondansetron (5-HT3 antagonist) inhibited the increase of serotonin concentration induced by cytotoxic drugs in the area postreama of ferrets Biog amines 9 163 175 1:CAS:528:DyaK3sXlt1Sgtw%3D%3D (Pubitemid 23003446)
35. T Endo M Nemoto M Minami M Yoshioka H Saito SH Parvez 1995 Changes in the afferent abdominal vagal nerve activity induced by cisplatin and copper sulfate in the ferret Biog Amines 11 399 407 1:CAS:528:DyaK2MXhtVSitr7K
36. T Endo M Nemoto Y Monma N Hamaue M Togashi M Hirafuji 1994 Combined effect of domperidone and granisetron on cisplatin-induced emesis in the ferret Pharmacometrics 47 435 442 1:CAS:528:DyaK2cXksV2rt7o%3D (Pubitemid 24205290)
37. European Medicines Agency (2006) Guideline on non-clinical and clinical development of medicinal products for the treatment of nausea and vomiting associated with cancer chemotherapy. CPMP/EWP/4937/03. In: EMEA (ed) London, UK
38. A Fink-Jensen ME Judge JB Hansen P Jacobsen L Turski J Olney T Honore 1992 Inhibition of cisplatin-induced emesis in ferrets by the non-NMDA receptor antagonists NBQX and CNQX Neurosci Lett 137 173 177 1:CAS:528:DyaK38Xit1yju7c%3D 1350077
39. LR Fitzpatrick RM Lambert CE Pendley GE Martin JS Bostwick GW Gessner JE Airey RD Youssefyeh RG Pendleton DL Decktor 1990 RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog J Pharmacol Exp Ther 254 450 455 2166791 (Pubitemid 20262080)
40. AP Florczyk JE Schurig WT Bradner 1982 Cisplatin-induced emesis in the Ferret: a new animal model Cancer Treat Rep 66 187 189 1:CAS:528:DyaL38XhsVc%3D 7198011 (Pubitemid 12254687)
41. AP Florczyk JE Schurig L Lenaz WT Bradner 1981 the ferret: a new animal model of cis-platinum induced emesis Proc Am Assoc Canc Res 22 228
42. N Fukunaka S Sagae R Kudo T Endo M Hirafuji M Minami 1998 Effects of granisetron and its combination with dexamethasone on cisplatin-induced delayed emesis in the ferret Gen Pharmacol 31 775 781 1:CAS:528:DyaK1cXntVCrsLo%3D 9809477 (Pubitemid 28520056)
43. Gandara WH Harvey GG Monaghan EA Perez PJ Hesketh 1993 Delayed emesis following high-dose cisplatin: a double-blind randomised comparative trial of ondansetron (GR 38032F) versus placebo Eur J Cancer 29A Suppl 1 S35 S38 8427724
44. CJ Gardner DR Armour DT Beattie JD Gale AB Hawcock GJ Kilpatrick DJ Twissell P Ward 1996 GR205171: a novel antagonist with high affinity for the tachykinin NK1 receptor, and potent broad-spectrum anti-emetic activity Regul Pept 65 45 53 1:CAS:528:DyaK28XkvFansro%3D 8876035 (Pubitemid 26273586)
45. CJ Gardner C Bountra KT Bunce TJ Dale CC Jordan DJ Twissell P Ward 1994 Anti-emetic activity of neurokinin NK1 receptor antagonists is mediated centrally Br J Pharmacol 112 516P
46. CJ Gardner DJ Twissell TJ Dale JD Gale CC Jordan GJ Kilpatrick C Bountra P Ward 1995 The broad-spectrum anti-emetic activity of the novel non-peptide tachykinin NK1 receptor antagonist GR203040 Br J Pharmacol 116 3158 3163 1:CAS:528:DyaK28XitFWktQ%3D%3D 8719790 (Pubitemid 26008856)
47. S Gonsalves J Watson C Ashton 1996 Broad spectrum antiemetic effects of CP-122, 721, a tachykinin NK1 receptor antagonist, in ferrets Eur J Pharmacol 305 181 185 1:CAS:528:DyaK28XjsVOks7g%3D 8813551 (Pubitemid 26197605)
48. CL Gooch FM Boissonade D Grundy 1998 Somatostatin analogue octreotide inhibits retching to cisplatin in anaesthetised ferret Gastroenterology 114 A1147
49. JA Gylys RN Wright WD Nicolosi JP Buyniski RR Crenshaw 1988 BMY-25801, an antiemetic agent free of D2-dopamine receptor antagonist properties J Pharmacol Exp Ther 244 830 837 1:CAS:528:DyaL1cXhvFyhsbk%3D 2978041 (Pubitemid 18090094)
50. K Haga K Inaba H Shoji Y Morimoto T Fukuda M Setoguchi 1993 The effects of orally administered Y-25130, a selective serotonin3-receptor antagonist, on chemotherapeutic agent-induced emesis Jpn J Pharmacol 63 377 383 1:CAS:528:DyaK2cXitlemsg%3D%3D 8107329 (Pubitemid 23350016)
51. K Haga K Inaba H Syoji 2000 The effect of azasetron hydrochloride (serotone (TM)) on delayed emesis induced by a chemotherapeutic agent, cisplatin Jpn Pharmacol Ther 28 285 290 1:CAS:528:DC%2BD3cXkslemsbo%3D (Pubitemid 30457090)
52. JJ Hale SG Mills M MacCoss CP Dorn PE Finke RJ Budhu RA Reamer SE Huskey D Luffer-Atlas BJ Dean EM McGowan WP Feeney SH Chiu MA Cascieri GG Chicchi MM Kurtz S Sadowski E Ber FD Tattersall NM Rupniak AR Williams W Rycroft R Hargreaves JM Metzger DE MacIntyre 2000 Phosphorylated morpholine acetal human neurokinin-1 receptor antagonists as water-soluble prodrugs J Med Chem 43 1234 1241 1:CAS:528:DC%2BD3cXht1yjtrc%3D 10737756 (Pubitemid 30173749)
53. JJ Hale SG Mills M MacCoss PE Finke MA Cascieri S Sadowski E Ber GG Chicchi M Kurtz J Metzger G Eiermann NN Tsou FD Tattersall NM Rupniak AR Williams W Rycroft R Hargreaves DE MacIntyre 1998 Structural optimization affording 2-(R)-(1-(R)-3, 5-bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro) phenyl-4-(3-oxo-1, 2, 4-triazol-5-yl)methylmorpholine, a potent, orally active, long-acting morpholine acetal human NK-1 receptor antagonist J Med Chem 41 4607 4614 1:CAS:528:DyaK1cXmtlansrY%3D 9804700 (Pubitemid 28516459)
54. R Hargreaves D Tattersall W Rycroft K Woodford T Ladduwahetty L Keown K Merchant C Swain AM MacLeod R Baker B Francis D Burns M Cascieri J Metzger DE MacIntyre DJ Williamson LL Iversen RG Hill 1994 Evidence that the anti-emetic effects of NK1 receptor antagonists are centrally mediated Can J Physiol Pharmacol 72 suppl 2 45
55. Harris AL, Cantwell BMJ (1986) Mechanisms and treatment of cytotoxic-induced nausea and vomiting. In: Davis CJ, Lake-Bakaar GV, Grahame-Smith DG (eds) Nausea and vomiting: mechanisms and treatment. Springer, Berlin, pp 78-93
56. J Hawthorn KJ Ostler PLR Andrews 1988 The role of the abdominal visceral innervation and 5-hydroxytryptamine M-receptors in vomiting induced by the cytotoxic drugs cyclophosphamide and cis-platin in the ferret Q J Exp Physiol 73 7 21 1:CAS:528:DyaL1cXhs1Wjsbw%3D 3347698 (Pubitemid 18028551)
57. Hesketh PJ (2005) Management of nausea and vomiting in cancer and cancer treatment. Jones and Barlett Publishers Inc., Sudbury
58. PJ Hesketh WK Murphy EP Lester DR Gandara A Khojasteh E Tapazoglou GP Sartiano DR White K Werner JM Chubb 1989 GR 38032F (GR-C507/75): a novel compound effective in the prevention of acute cisplatin-induced emesis J Clin Oncol 7 700 705 1:STN:280:DyaL1M3jsFKruw%3D%3D 2523957 (Pubitemid 19145589)
59. GA Higgins GJ Kilpatrick KT Bunce BJ Jones MB Tyers 1989 5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret Br J Pharmacol 97 247 255 1:CAS:528:DyaL1MXktFOhsLc%3D 2720310 (Pubitemid 19113970)
60. GJ Hollingworth EJ Carlson JL Castro GG Chicchi N Clark LC Cooper O Dirat JD Salvo JM Elliott R Kilburn MM Kurtz W Rycroft FD Tattersall KL Tsao CJ Swain 2006 Novel lactam NK1 antagonists with anti-emetic activity Bioorg Med Chem Lett 16 1197 1201 1:CAS:528:DC%2BD28XoslyqsA%3D%3D 16384700 (Pubitemid 43142991)
61. AM Holmes JA Rudd FD Tattersall Q Aziz PLR Andrews 2009 Opportunities for the replacement of animals in the study of nausea and vomiting Br J Pharmacol 157 865 880 1:CAS:528:DC%2BD1MXhtVChu7nO 19371333
62. J Horn RJ de Haan M Vermeulen PG Luiten M Limburg 2001 Nimodipine in animal model experiments of focal cerebral ischemia: a systematic review Stroke 32 2433 2438 1:CAS:528:DC%2BD3MXotVaku7Y%3D 11588338 (Pubitemid 32954819)
63. J Horn M Limburg 2001 Calcium antagonists for ischemic stroke: a systematic review Stroke 32 570 576 1:CAS:528:DC%2BD3MXhtlymsb0%3D 11157199 (Pubitemid 32155253)
64. T Ito N Yoshida Y Miura H Omoya T Karasawa 1990 Antiemetic effects of AS-5370, a novel serotonin 5-HT3 receptor antagonist Eur J Pharmacol 183 1214 1215 (Pubitemid 20288067)
65. IT Jantunen VV Kataja TT Muhonen 1997 An overview of randomised studies comparing 5-HT3 receptor antagonists to conventional anti-emetics in the prophylaxis of acute chemotherapy-induced vomiting Eur J Cancer 33 66 74 1:CAS:528:DyaK2sXit1yitLs%3D 9071902 (Pubitemid 27099570)
66. T Kamato H Ito Y Nagakura A Nishida H Yuki M Yamano K Miyata 1993 Mechanisms of cisplatin- and m-chlorophenylbiguanide-induced emesis in ferrets Eur J Pharmacol 238 369 376 1:CAS:528:DyaK3sXlslektb0%3D 8405104 (Pubitemid 23214452)
67. T Kamato K Miyata H Ito H Yuki M Yamano K Honda 1991 Antiemetic effects of YM060, a potent and selective serotonin (5HT)3-receptor antagonist, in ferrets and dogs Jpn J Pharmacol 57 387 395 1:CAS:528:DyaK38XltFeruw%3D%3D 1813664
68. Kilkenny C (2008) Systematic reviews of animal research. Available online at: http://www.nc3rs.org.uk/downloaddoc.asp?id=695
69. JH Kim IS Yoon BH Lee SH Choi JH Lee JH Lee SM Jeong SC Kim CK Park SM Lee SY Nah 2005 Effects of Korean red ginseng extract on cisplatin-induced nausea and vomiting Arch Pharm Res 28 680 684 1:CAS:528:DC%2BD2MXmtVOrsLw%3D 16042077
70. AG King GJ Sanger 2005 Effect of a selective and potent central nervous system penetrant, neurokinin-3 receptor antagonist (SB-222200), on cisplatin-induced emesis in the ferret Neurosci Lett 376 5 8 1:CAS:528:DC%2BD2MXptlGhsA%3D%3D 15694264 (Pubitemid 40202927)
71. MG Kris LX Cubeddu RJ Gralla D Cupissol LB Tyson E Venkatraman HD Homesley 1996 Are more antiemetic trials with a placebo necessary? Report of patient data from randomized trials of placebo antiemetics with cisplatin Cancer 78 2193 2198 1:STN:280:DyaK2s%2Fns1Sqsw%3D%3D 8918414 (Pubitemid 26367614)
72. MG Kris RJ Gralla RA Clark LB Tyson JP O'Connell MS Wertheim DP Kelsen 1985 Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin J Clin Oncol 3 1379 1384 1:STN:280:DyaL28%2FhtVCltw%3D%3D 4045527 (Pubitemid 15244935)
73. Y Kubota K Mihara F Ishii K Ohno H Ogata M Makimura N Kikuchi T Kitano 2004 Effectiveness of anti-emetics for the prophylaxis of cisplatin-induced delayed emesis: a systematic review Yakugaku Zasshi 124 1 11 1:CAS:528:DC%2BD2cXpsF2htLo%3D 14768349 (Pubitemid 41320931)
74. B Lasheras A Berjon R Montanes J Roca G Romero MJ Ramirez J Del Rio 1996 Pharmacological properties of quinoxaline derivatives as a new class of 5-HT3 receptor antagonists Arzneimittelforschung 46 401 406 1:CAS:528: DyaK28Xjt1Shtbc%3D 8740088 (Pubitemid 26146758)
75. AH Lau KK Kan HW Lai MP Ngan JA Rudd MK Wai DT Yew 2005 Action of ondansetron and CP-99, 994 to modify behavior and antagonize cisplatin-induced emesis in the ferret Eur J Pharmacol 506 241 247 1:CAS:528:DC%2BD2cXhtFGgs77J 15627434 (Pubitemid 41071396)
76. A Lehmann L Karrberg 1996 Effects of N-methyl-D-aspartate receptor antagonists on cisplatin-induced emesis in the ferret Neuropharmacology 35 475 481 1:CAS:528:DyaK28XjvVCgs78%3D 8793910 (Pubitemid 26189391)
77. YL Liu NM Malik GJ Sanger PL Andrews 2006 Ghrelin alleviates cancer chemotherapy-associated dyspepsia in rodents Cancer Chemother Pharmacol 58 326 333 1:CAS:528:DC%2BD28XkvFOis74%3D 16435157 (Pubitemid 43800735)
78. MR Macleod T O'Collins LL Horky DW Howells GA Donnan 2005 Systematic review and meta-analysis of the efficacy of melatonin in experimental stroke J Pineal Res 38 35 41 1:CAS:528:DC%2BD2MXpsFersA%3D%3D 15617535 (Pubitemid 40139308)
79. MR Macleod T O'Collins LL Horky DW Howells GA Donnan 2005 Systematic review and metaanalysis of the efficacy of FK506 in experimental stroke J Cereb Blood Flow Metab 25 713 721 1:CAS:528:DC%2BD2MXlsFegsr4%3D 15703698 (Pubitemid 40705606)
80. MR Macleod T O'Collins DW Howells GA Donnan 2004 Pooling of animal experimental data reveals influence of study design and publication bias Stroke 35 1203 1208 15060322 (Pubitemid 38543544)
81. HE Marr PT Davey PR Blower 1992 The effect of dexamethasone, alone or in combination with granisetron, on cisplatin-induced emesis in the ferret Br J Pharmacol 104 371P
82. HE Marr PT Davey EA Boyle PR Blower 1994 Further studies of the antiemetic activity of granisetron against whole body X-irradiation or cisplatin-induced emesis in the ferret Pharmacology 48 283 292 1:CAS:528:DyaK2cXitlGrsb4%3D 8016189 (Pubitemid 24103614)
83. HE Marr PT Davey EA Boyle PR Blower 1994 The antiemetic activity of granisetron against cytostatic-treatment-induced emesis in 10- to 13-week-old ferrets J Cancer Res Clin Oncol 120 204 207 1:CAS:528:DyaK2cXlt1Gjsro%3D 8288674 (Pubitemid 24028558)
84. M Martin 1996 The severity and pattern of emesis following different cytotoxic agents Oncology 53 Suppl 1 26 31 8692547 (Pubitemid 26335146)
85. M Marty JP Kleisbauer P Fournel A Vergnenegre P Carles Y Loria-Kanza C Simonetta KM de Bruijn 1995 Is Navoban (tropisetron) as effective as Zofran (ondansetron) in cisplatin-induced emesis? The French Navoban Study Group Anticancer Drugs 6 Suppl 1 15 21 1:CAS:528:DyaK2MXktlKlsLc%3D 7749165
86. T Matsui T Sugiura H Nakai S Iguchi S Shigeoka H Takada Y Odagaki Y Nagao Y Ushio K Ohmoto, et al. 1992 Novel 5-HT3 antagonists. Isoquinolinones and 3-aryl-2-pyridones J Med Chem 35 3307 3319 1:CAS:528:DyaK38XlsFSrt7w%3D 1527780
87. JN Matthews DG Altman 1996 Interaction 3: How to examine heterogeneity BMJ 313 862 1:STN:280:DyaK2s%2FisVenuw%3D%3D 8870577 (Pubitemid 26335214)
88. RA Matthews 2008 Medical progress depends on animal models-doesn't it? J R Soc Med 101 95 98 18299631 (Pubitemid 351498389)
89. LE McCarthy HL Borison 1974 Respiratory mechanics of vomiting in decerebrate cats Am J Physiol 226 738 743 1:STN:280:DyaE2c7isVKitA%3D%3D 4817428
90. RC Miller M Galvan MW Gittos PLM Van Giersbergen PC Moser JR Fozard 1993 Pharmacological properties of dolasetron, a potent and selective antagonist at 5-HT3 receptors Drug Dev Res 28 87 93 1:CAS:528:DyaK3sXhtl2lu78%3D (Pubitemid 23041487)
91. M Minami T Endo K Kikuchi E Ihira M Hirafuji N Hamaue Y Monma T Sakurada K Tan-no K Kisara 1998 Antiemetic effects of sendide, a peptide tachykinin NK1 receptor antagonist, in the ferret Eur J Pharmacol 363 49 55 1:CAS:528:DyaK1cXotFWjtLk%3D 9877081 (Pubitemid 29056216)
92. M Minami T Endo Y Monma Y Shiroshita 1991 Pharmacoogy of emesis induced by anti cancer drugs J Toxicol Sci 16 suppl 2 35 39 1:CAS:528:DyaK38Xmt1Grtbc%3D
93. M Minami T Endo H Tamakai T Ogawa N Hamaue M Hirafuji Y Monma M Yoshioka K Hagihara 1997 Antiemetic effects of N-3389, a newly synthesized 5-HT3 and 5-HT4 receptor antagonist, in ferrets Eur J Pharmacol 321 333 342 1:CAS:528:DyaK2sXhvFKju7o%3D 9085045 (Pubitemid 27105936)
94. WD Miner GJ Sanger 1986 Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism Br J Pharmacol 88 497 499 1:STN:280:DyaL283pslehtQ%3D%3D 3742146 (Pubitemid 16066912)
95. WD Miner GJ Sanger DH Turner 1986 Comparison of the effect of BRL 24924, metoclopramide and domperidone on cisplatin-induced emesis in the ferret Br J Pharmacol 88 374P
96. WD Miner GJ Sanger DH Turner 1987 Evidence that 5-hydroxytryptamine3 receptors mediate cytotoxic drug and radiation-evoked emesis Br J Cancer 56 159 162 1:CAS:528:DyaL2sXlsVyjs7g%3D 3311109 (Pubitemid 17155531)
97. D Moher DJ Cook S Eastwood I Olkin D Rennie DF Stroup 1999 Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses Lancet 354 1896 1900 1:STN:280:DC%2BD3c%2FkvFCgtQ%3D%3D 10584742
98. I Monkovic D Willner MA Adam M Brown RR Crenshaw CE Fuller PF Juby GM Luke JA Matiskella TA Montzka 1988 Substituted benzamides. 1. Potential nondopaminergic antagonists of chemotherapy-induced nausea and emesis J Med Chem 31 1548 1558 1:CAS:528:DyaL1cXksFCntr8%3D 3397992
99. H Nakayama H Yamakuni M Higaki H Ishikawa K Imazumi M Matsuo S Mutoh 2005 Antiemetic activity of FK1052, a 5-HT3- and 5-HT4-receptor antagonist, in Suncus murinus and ferrets J Pharmacol Sci 98 396 403 1:CAS:528: DC%2BD2MXps1OmtLc%3D 16079468 (Pubitemid 41297013)
100. RM Navari S Madajewicz N Anderson NS Tchekmedyian W Whaley H Garewal TM Beck AY Chang B Greenberg KC Caldwell, et al. 1995 Oral ondansetron for the control of cisplatin-induced delayed emesis: a large, multicenter, double-blind, randomized comparative trial of ondansetron versus placebo J Clin Oncol 13 2408 2416 1:CAS:528:DyaK2MXoslaqtbc%3D 7666101
101. Nuffield Council on Bioethics (2005) The ethics of research involving animals. In: Bioethics NCo (ed) London
102. M Ohta T Suzuki T Furuya H Kurihara T Tokunaga K Miyata I Yanagisawa 1996 Novel 5-hydroxytryptamine (5-HT3) receptor antagonists. III. Pharmacological evaluations and molecular modeling studies of optically active 4,5,6,7-tetrahydro-1H-benzimidazole derivatives Chem Pharm Bull (Tokyo) 44 1707 1716 1:CAS:528:DyaK28XlvFKqurg%3D (Pubitemid 26342285)
103. A Ozaki T Sukamoto 1999 Improvement of cisplatin-induced emesis and delayed gastric emptying by KB-R6933, a novel 5-HT3 receptor antagonist Gen Pharmacol 33 283 288 1:CAS:528:DyaK1MXls1yrsLc%3D 10480662 (Pubitemid 29376467)
104. N Percie du Sert JA Rudd R Moss PL Andrews 2009 The delayed phase of cisplatin-induced emesis is mediated by the area postrema and not the abdominal visceral innervation in the ferret Neurosci Lett 465 16 20 1:CAS:528: DC%2BD1MXhtFGkurvJ 19733218
105. P Pound S Ebrahim P Sandercock MB Bracken I Roberts 2004 Where is the evidence that animal research benefits humans? BMJ 328 514 517 14988196 (Pubitemid 38293622)
106. P Preziosi M D'Amato R Del Carmine M Martire G Pozzoli P Navarra 1992 The effects of 5-HT3 receptor antagonists on cisplatin-induced emesis in the pigeon Eur J Pharmacol 221 343 350 1:CAS:528:DyaK38Xmt1Khsbc%3D 1426010
107. MT Price JE Olney 1990 Excitatory amino acid antagonists as anti-emetics Soc Neurosci Abstr 16 377
108. DJ Reynolds NA Barber DG Grahame-Smith RA Leslie 1991 Cisplatin-evoked induction of c-fos protein in the brainstem of the ferret: the effect of cervical vagotomy and the anti-emetic 5-HT3 receptor antagonist granisetron (BRL 43694) Brain Res 565 231 236 1:CAS:528:DyaK38XhsFGhsg%3D%3D 1668810
109. F Roila PJ Hesketh J Herrstedt 2006 Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference Ann Oncol 17 20 28 1:STN:280: DC%2BD28%2FkvVKmtQ%3D%3D 16314401 (Pubitemid 43033835)
110. Rudd JA, Andrews PLR (2005) Mechanisms of acute and delayed Nausea and vomiting induced by anticancer therapies. In: Hesketh P (ed) Management of Nausea and vomiting in cancer and cancer treatment. Jones and Barlett Publishers, Inc., Sudbury, pp 15-66
111. JA Rudd KT Bunce RJ Naylor 1992 The effect of 8-OH-DPAT on drug-induced emesis in the ferret Br J Pharmacol 106 101P
112. JA Rudd KT Bunce RJ Naylor 1996 The interaction of dexamethasone with ondansetron on drug-induced emesis in the ferret Neuropharmacology 35 91 97 1:CAS:528:DyaK28XhtlOhsLg%3D 8684601 (Pubitemid 26066840)
113. JA Rudd CH Cheng RJ Naylor 1998 Serotonin-independent model of cisplatin-induced emesis in the ferret Jpn J Pharmacol 78 253 260 1:CAS:528:DyaK1cXnslykt7Y%3D 9869258 (Pubitemid 28554191)
114. JA Rudd CC Jordan RJ Naylor 1994 Profiles of emetic action of cisplatin in the ferret: a potential model of acute and delayed emesis Eur J Pharmacol 262 R1 R2 1:CAS:528:DyaK2cXlvFCrs7Y%3D 7813558
115. JA Rudd CC Jordan RJ Naylor 1996 The action of the NK1 tachykinin receptor antagonist, CP 99, 994, in antagonizing the acute and delayed emesis induced by cisplatin in the ferret Br J Pharmacol 119 931 936 1:CAS:528:DyaK28XmvVSmsb8%3D 8922742 (Pubitemid 26366488)
116. Rudd JA, Kan KW, Ngan MP, Okuno T, Sam TS (2001) Anti-emetic action of intranasally administered metoclopramide in the ferret. Presented at: 7th Hong Kong Pharmacology Society Scientific meeting in Association with the Zhjiang Pharmacological Society, Hong Kong, China, 16-18 October
117. JA Rudd RJ Naylor 1994 Effects of 5-HT3 receptor antagonists on models of acute and delayed emesis induced by cisplatin in the ferret Neuropharmacology 33 1607 1608 1:CAS:528:DyaK2MXjsVyrtrY%3D 7760983
118. JA Rudd RJ Naylor 1994 Modulation of emesis by 5HT1A receptors Pathophysiology 1 267 268
119. JA Rudd RJ Naylor 1996 An interaction of ondansetron and dexamethasone antagonizing cisplatin-induced acute and delayed emesis in the ferret Br J Pharmacol 118 209 214 1:CAS:528:DyaK28Xjt1Ojtb0%3D 8735616 (Pubitemid 26149263)
120. JA Rudd RJ Naylor 1997 The actions of ondansetron and dexamethasone to antagonise cisplatin-induced emesis in the ferret Eur J Pharmacol 322 79 82 1:CAS:528:DyaK2sXit1GnurY%3D 9088874 (Pubitemid 27117927)
121. JA Rudd MP Ngan MK Wai 1998 5-HT3 receptors are not involved in conditioned taste aversions induced by 5-hydroxytryptamine, ipecacuanha or cisplatin Eur J Pharmacol 352 143 149 1:CAS:528:DyaK1cXksVyqtr4%3D 9716348 (Pubitemid 28345111)
122. JA Rudd MP Ngan MK Wai AG King J Witherington PLR Andrews GJ Sanger 2006 Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin Neurosci Lett 392 79 83 1:CAS:528:DC%2BD2MXhtlSjsLfJ 16182445 (Pubitemid 41757580)
123. Rudd JA, Sam TS, Ngan MP (2006) A COX and LOX inhibitor regimen fails to mimic the action of dexamethasone on cisplatin-induced acute and delayed emesis in the Ferret. IUPHAR-2006, Beijing
124. P Ruff W Paska L Goedhals P Pouillart A Riviere D Vorobiof B Bloch A Jones C Martin R Brunet, et al. 1994 Ondansetron compared with granisetron in the prophylaxis of cisplatin-induced acute emesis: a multicentre double-blind, randomised, parallel-group study. The Ondansetron and Granisetron Emesis Study Group Oncology 51 113 118 1:STN:280:DyaK2c%2FovFSrsg%3D%3D 8265095 (Pubitemid 24008652)
125. NM Rupniak FD Tattersall AR Williams W Rycroft EJ Carlson MA Cascieri S Sadowski E Ber JJ Hale SG Mills M MacCoss E Seward I Huscroft S Owen CJ Swain RG Hill RJ Hargreaves 1997 In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonists Eur J Pharmacol 326 201 209 1:CAS:528:DyaK2sXjtlWnsrk%3D 9196273 (Pubitemid 27214550)
126. Russell WM, Burch RL (1959) The principles of humane experimental technique. Universities Federation For Animal Welfare (UFAW)
127. Rycroft W, Tattersall D, Ber E, Cascieri M, Hale JJ, Hill RG, MacCoss M, Mills SG, Sadowski S, Hargreaves R (1996) The anti-emetic actions of L-742,694, poster
128. TS Sam SW Chan JA Rudd JH Yeung 2001 Action of glucocorticoids to antagonise cisplatin-induced acute and delayed emesis in the ferret Eur J Pharmacol 417 231 237 1:CAS:528:DC%2BD3MXjtFGnu74%3D 11334855 (Pubitemid 32385771)
129. TS Sam KK Kan MP Ngan JA Rudd JH Yeung 2003 Action of metyrapone and tetracosactrin to modify cisplatin-induced acute and delayed emesis in the ferret Eur J Pharmacol 466 163 168 1:CAS:528:DC%2BD3sXisV2rsrk%3D 12679153 (Pubitemid 36385102)
130. TS Sam MP Ngan D Riendeau A Robichaud JA Rudd 2007 Action of cyclooxygenase inhibitors and a leukotriene biosynthesis inhibitor on cisplatin-induced acute and delayed emesis in the ferret J Pharmacol Sci 103 189 200 1:CAS:528:DC%2BD2sXisFGnsrw%3D 17310074 (Pubitemid 46294651)
131. JE Schurig AP Florczyk WC Rose WT Bradner 1982 Antiemetic activity of butorphanol against cisplatin-induced emesis in ferrets and dogs Cancer Treat Rep 66 1831 1835 1:CAS:528:DyaL38XlsFKgurY%3D 6889914 (Pubitemid 12005304)
132. Y Shiroshita M Minami T Endo Y Monma M Asaka H Itoh T Ikeda H Matsumoto T Satoh 1993 The protective effect of 4-hydroxy-2-methyl-N-[2-(tetrazol-5-yl)- phenyl]-2H-1, 2-benzothiazine-3-carboxamide-1, 1-dioxide monosodium salt (HX-1920) on cisplatin-induced toxicity in rats J Toxicol Sci 18 31 41 1:STN:280:DyaK3s3jtlajsg%3D%3D 8474148 (Pubitemid 23093613)
133. Y Shiroshita M Minami T Endo M Takahashi Y Monma I Hiromishi R Yokoyama K Matsumoto 1992 Effects of HX-1920 on cisplatin-induced toxicity in mice, rat and ferrets Jpn J Pharmacol 58 419P
134. L Singh MJ Field J Hughes BS Kuo N Suman-Chauhan BR Tuladhar DS Wright RJ Naylor 1997 The tachykinin NK1 receptor antagonist PD 154075 blocks cisplatin-induced delayed emesis in the ferret Eur J Pharmacol 321 209 216 1:CAS:528:DyaK2sXhvVWmtbo%3D 9063690 (Pubitemid 27089553)
135. D Spina 2004 The potential of PDE4 inhibitors in respiratory disease Curr Drug Targets Inflamm Allergy 3 231 236 1:CAS:528:DC%2BD2cXmvVemtbw%3D 15379590 (Pubitemid 39206651)
136. R Stables PLR Andrews HE Bailey B Costall SJ Gunning J Hawthorn RJ Naylor MB Tyers 1987 Antiemetic properties of the 5HT3-receptor antagonist, GR38032F Cancer Treat Rev 14 333 336 1:CAS:528:DyaL1cXhsl2qs7g%3D 2964267 (Pubitemid 18065035)
137. S Taniguchi K Hagihara T Hamada M Minami T Endo M Tsuchiyama 2004 The inhibitory action of indisetron hydrochloride, a 5-HT3 receptor antagonist,
138. D Tattersall CT Dourish M Duchnowski C Swain SD Iversen 1990 The anti-emetic action of the novel 5-HT3 receptor antagonist L-683, 877 in the ferret Eur J Pharmacol 183 1966 1967 (Pubitemid 20318758)
139. D Tattersall N Newberry MS Beer M Rigby M Gilbert JJ Maguire N Mudukotuwa M Duchnowski AT MacKnight C Swain C Kneen CT Dourish 1992 L-683, 877: Pharmacological Profile of a Novel 5-HT3 Receptor Antagonist Drug Dev Res 25 17 28 1:CAS:528:DyaK38Xht1Sktbw%3D
140. FD Tattersall W Rycroft M Cumberbatch G Mason S Tye DJ Williamson JJ Hale SG Mills PE Finke M MacCoss S Sadowski E Ber M Cascieri RG Hill DE MacIntyre RJ Hargreaves 2000 The novel NK1 receptor antagonist MK-0869 (L-754, 030) and its water soluble phosphoryl prodrug, L-758, 298, inhibit acute and delayed cisplatin-induced emesis in ferrets Neuropharmacology 39 652 663 1:CAS:528:DC%2BD3cXhtFWqs7w%3D 10728886 (Pubitemid 30089315)
141. FD Tattersall W Rycroft B Francis D Pearce K Merchant AM MacLeod T Ladduwahetty L Keown C Swain R Baker M Cascieri E Ber J Metzger DE MacIntyre RG Hill RJ Hargreaves 1996 Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets Neuropharmacology 35 1121 1129 1:CAS:528:DyaK2sXnsFKrtA%3D%3D 9121615 (Pubitemid 27008187)
142. FD Tattersall W Rycroft RJ Hargreaves RG Hill 1993 The tachykinin NK1 receptor antagonist CP-99, 994 attenuates cisplatin induced emesis in the ferret Eur J Pharmacol 250 R5 R6 1:CAS:528:DyaK2cXksFKitA%3D%3D 8119305
143. The Cochrane Collaboration® (2002) Open Learning Material
144. M Tsuchiya Y Fujiwara Y Kanai M Mizutani K Shimada O Suga S Ueda JW Watson A Nagahisa 2002 Anti-emetic activity of the novel nonpeptide tachykinin NK1 receptor antagonist ezlopitant (CJ-11, 974) against acute and delayed cisplatin-induced emesis in the ferret Pharmacology 66 144 152 1:CAS:528:DC%2BD38XnslWqurg%3D 12372904 (Pubitemid 35316926)
145. Twissell DJ, Bountra C, Bunce KT, Dale TJ, Gardner CJ, Jordan CC, Ward P (1993) Anti-emetic properties of a non-peptide neurokinin NK1 antagonist, CP-99,994, in ferrets
146. MD Van Sickle LD Oland K Mackie JS Davison KA Sharkey 2003 Delta9-tetrahydrocannabinol selectively acts on CB1 receptors in specific regions of dorsal vagal complex to inhibit emesis in ferrets Am J Physiol Gastrointest Liver Physiol 285 G566 G576 12791597
147. Y Watanabe M Okamoto T Ishii S Takatsuka H Taniguchi M Nagasaki A Saito 2008 Long-lasting anti-emetic effect of T-2328, a novel NK(1) antagonist J Pharmacol Sci 107 151 158 1:CAS:528:DC%2BD1cXotVyhsrs%3D 18544900 (Pubitemid 351931015)
148. JW Watson SF Gonsalves AA Fossa S McLean T Seeger S Obach PLR Andrews 1995 The anti-emetic effects of CP-99, 994 in the ferret and the dog: role of the NK1 receptor Br J Pharmacol 115 84 94 1:CAS:528:DyaK2MXlsV2ru7o%3D 7544198
149. H Yamakuni H Nakayama S Matsui K Imazumi M Matsuo S Mutoh 2006 Inhibitory effect of zacopride on Cisplatin-induced delayed emesis in ferrets J Pharmacol Sci 101 99 102 1:CAS:528:DC%2BD28XlsVGns7Y%3D 16651699 (Pubitemid 43765341)
150. H Yamakuni H Sawai-Nakayama K Imazumi Y Maeda M Matsuo T Manda S Mutoh 2002 Resiniferatoxin antagonizes cisplatin-induced emesis in dogs and ferrets Eur J Pharmacol 442 273 278 1:CAS:528:DC%2BD38XksVShsLg%3D 12065081 (Pubitemid 34626203)
151. N Yoshida H Omoya T Ito 1992 DAT-582, a novel serotonin3 receptor antagonist, is a potent and long-lasting antiemetic agent in the ferret and dog J Pharmacol Exp Ther 260 1159 1165 1:CAS:528:DyaK38XitVOlsr8%3D 1532032
152. N Yoshida H Omoya S Kato T Ito 1992 5-HT3 receptor antagonist effects of DAT-582, (R) enantiomer of AS-5370 Eur J Pharmacol 216 435 440 1:CAS:528:DyaK38Xlt1ChsrY%3D 1425931
153. N Yoshida H Omoya S Kato T Ito 1993 Pharmacological effects of the new gastroprokinetic agent mosapride citrate and its metabolites in experimental animals Arzneimittelforschung 43 1078 1083 1:CAS:528:DyaK2cXitlehsw%3D%3D 8267674 (Pubitemid 23311886)
154. N Yoshida H Omoya T Une T Ito S kato 1991 Pharmacological profile of the stereoisomers of AS-5370, a novel 5HT3 receptor antagonist Jpn J Pharmacol 55 sup 1 385
155. T Yoshikawa N Yoshida K Hosoki 1996 Involvement of dopamine D3 receptors in the area postrema in R(+)-7-OH-DPAT-induced emesis in the ferret Eur J Pharmacol 301 143 149 1:CAS:528:DyaK28XjtFaqu7w%3D 8773458
156. T Yoshikawa N Yoshida M Oka 2001 Central antiemetic effects of AS-8112, a dopamine D2, D3, and 5-HT(3) receptor antagonist, in ferrets Eur J Pharmacol 431 361 364 1:CAS:528:DC%2BD3MXos1Cmtro%3D 11730730 (Pubitemid 33145415)
157. T Yoshikawa N Yoshida M Oka 2001 The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D2, D3 and 5-HT3 receptors antagonist Br J Pharmacol 133 253 260 1:CAS:528:DC%2BD3MXktVSltrc%3D 11350861 (Pubitemid 32507044)
158. RD Youssefyeh HF Campbell JE Airey S Klein M Schnapper M Powers R Woodward W Rodriguez S Golec W Studt, et al. 1992 Development of high-affinity 5-HT3 receptor antagonists. 2. Two novel tricyclic benzamides J Med Chem 35 903 911 1:CAS:528:DyaK38XktF2ru7k%3D 1548679
159. RD Youssefyeh HF Campbell S Klein JE Airey P Darkes M Powers M Schnapper K Neuenschwander LR Fitzpatrick CE Pendley, et al. 1992 Development of high-affinity 5-HT3 receptor antagonists. 1. Initial structure-activity relationship of novel benzamides J Med Chem 35 895 903 1:CAS:528: DyaK38Xht1ylsLo%3D 1312602